The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sialylated Human Milk Oligosaccharides (HMO) Market Research Report 2024
Synopsis
Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3’-Sialyllactose (3’-SL) and 6′-sialyllactose (6’-SL) are two simplest sialylated HMOs. The global market for Human Milk Oligosaccharides (HMO) was estimated to be worth US$ 467.7 million in 2023 and is forecast to a readjusted size of US$ 1227.5 million by 2030 with a CAGR of 14.5% during the forecast period 2024-2030.
The global Sialylated Human Milk Oligosaccharides (HMO) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sialylated Human Milk Oligosaccharides (HMO) include Chr. Hansen (Jennewein Biotechnologie GmgH), DSM (Glycom A/S), Inbiose, Kyowa Hakko Bio, GeneChem Inc. and FrieslandCampina Ingredients, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sialylated Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sialylated Human Milk Oligosaccharides (HMO).
Report Scope
The Sialylated Human Milk Oligosaccharides (HMO) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sialylated Human Milk Oligosaccharides (HMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sialylated Human Milk Oligosaccharides (HMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chr. Hansen (Jennewein Biotechnologie GmgH)
DSM (Glycom A/S)
Inbiose
Kyowa Hakko Bio
GeneChem Inc.
FrieslandCampina Ingredients
Segment by Type
3'-Sialyllactose
6'-Sialyllactose
Segment by Application
Infant Formula
Food
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sialylated Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sialylated Human Milk Oligosaccharides (HMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3’-Sialyllactose (3’-SL) and 6′-sialyllactose (6’-SL) are two simplest sialylated HMOs. The global market for Human Milk Oligosaccharides (HMO) was estimated to be worth US$ 467.7 million in 2023 and is forecast to a readjusted size of US$ 1227.5 million by 2030 with a CAGR of 14.5% during the forecast period 2024-2030.
The global Sialylated Human Milk Oligosaccharides (HMO) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sialylated Human Milk Oligosaccharides (HMO) include Chr. Hansen (Jennewein Biotechnologie GmgH), DSM (Glycom A/S), Inbiose, Kyowa Hakko Bio, GeneChem Inc. and FrieslandCampina Ingredients, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sialylated Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sialylated Human Milk Oligosaccharides (HMO).
Report Scope
The Sialylated Human Milk Oligosaccharides (HMO) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sialylated Human Milk Oligosaccharides (HMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sialylated Human Milk Oligosaccharides (HMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chr. Hansen (Jennewein Biotechnologie GmgH)
DSM (Glycom A/S)
Inbiose
Kyowa Hakko Bio
GeneChem Inc.
FrieslandCampina Ingredients
Segment by Type
3'-Sialyllactose
6'-Sialyllactose
Segment by Application
Infant Formula
Food
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sialylated Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sialylated Human Milk Oligosaccharides (HMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sialylated Human Milk Oligosaccharides (HMO) Market Overview
1.1 Product Overview and Scope of Sialylated Human Milk Oligosaccharides (HMO)
1.2 Sialylated Human Milk Oligosaccharides (HMO) Segment by Type
1.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Value Comparison by Type (2024-2030)
1.2.2 3'-Sialyllactose
1.2.3 6'-Sialyllactose
1.3 Sialylated Human Milk Oligosaccharides (HMO) Segment by Application
1.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Value by Application: (2024-2030)
1.3.2 Infant Formula
1.3.3 Food
1.3.4 Others
1.4 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts
1.4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue 2019-2030
1.4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales 2019-2030
1.4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sialylated Human Milk Oligosaccharides (HMO) Market Competition by Manufacturers
2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturers (2019-2024)
2.4 Global Sialylated Human Milk Oligosaccharides (HMO) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Product Type & Application
2.7 Sialylated Human Milk Oligosaccharides (HMO) Market Competitive Situation and Trends
2.7.1 Sialylated Human Milk Oligosaccharides (HMO) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sialylated Human Milk Oligosaccharides (HMO) Players Market Share by Revenue
2.7.3 Global Sialylated Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sialylated Human Milk Oligosaccharides (HMO) Retrospective Market Scenario by Region
3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2019-2030
3.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2019-2024
3.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2025-2030
3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2019-2030
3.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2019-2024
3.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2025-2030
3.4 North America Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.4.1 North America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.4.3 North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.5.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.5.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.6.1 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.6.3 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.7.1 Latin America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.7.3 Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
4.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024)
4.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030)
4.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
4.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024)
4.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030)
4.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
5.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024)
5.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030)
5.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
5.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
5.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024)
5.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030)
5.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
5.3 Global Sialylated Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
6.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Corporation Information
6.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Description and Business Overview
6.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.1.5 Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments/Updates
6.2 DSM (Glycom A/S)
6.2.1 DSM (Glycom A/S) Corporation Information
6.2.2 DSM (Glycom A/S) Description and Business Overview
6.2.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.2.5 DSM (Glycom A/S) Recent Developments/Updates
6.3 Inbiose
6.3.1 Inbiose Corporation Information
6.3.2 Inbiose Description and Business Overview
6.3.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.3.5 Inbiose Recent Developments/Updates
6.4 Kyowa Hakko Bio
6.4.1 Kyowa Hakko Bio Corporation Information
6.4.2 Kyowa Hakko Bio Description and Business Overview
6.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.4.5 Kyowa Hakko Bio Recent Developments/Updates
6.5 GeneChem Inc.
6.5.1 GeneChem Inc. Corporation Information
6.5.2 GeneChem Inc. Description and Business Overview
6.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.5.5 GeneChem Inc. Recent Developments/Updates
6.6 FrieslandCampina Ingredients
6.6.1 FrieslandCampina Ingredients Corporation Information
6.6.2 FrieslandCampina Ingredients Description and Business Overview
6.6.3 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.6.5 FrieslandCampina Ingredients Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Chain Analysis
7.2 Sialylated Human Milk Oligosaccharides (HMO) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sialylated Human Milk Oligosaccharides (HMO) Production Mode & Process
7.4 Sialylated Human Milk Oligosaccharides (HMO) Sales and Marketing
7.4.1 Sialylated Human Milk Oligosaccharides (HMO) Sales Channels
7.4.2 Sialylated Human Milk Oligosaccharides (HMO) Distributors
7.5 Sialylated Human Milk Oligosaccharides (HMO) Customers
8 Sialylated Human Milk Oligosaccharides (HMO) Market Dynamics
8.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Trends
8.2 Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
8.3 Sialylated Human Milk Oligosaccharides (HMO) Market Challenges
8.4 Sialylated Human Milk Oligosaccharides (HMO) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Sialylated Human Milk Oligosaccharides (HMO) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sialylated Human Milk Oligosaccharides (HMO) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Sialylated Human Milk Oligosaccharides (HMO) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sialylated Human Milk Oligosaccharides (HMO) Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sialylated Human Milk Oligosaccharides (HMO), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Product Type & Application
Table 12. Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sialylated Human Milk Oligosaccharides (HMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sialylated Human Milk Oligosaccharides (HMO) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024) & (Tons)
Table 18. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2019-2024)
Table 19. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2025-2030) & (Tons)
Table 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2025-2030)
Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2024)
Table 23. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2025-2030)
Table 25. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 27. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 28. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 32. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 33. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) by Type (2019-2024)
Table 51. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) by Type (2025-2030)
Table 52. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2024)
Table 53. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2025-2030)
Table 54. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2024)
Table 57. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2025-2030)
Table 58. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Type (2019-2024)
Table 59. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Type (2025-2030)
Table 60. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) by Application (2019-2024)
Table 61. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) by Application (2025-2030)
Table 62. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2024)
Table 63. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2025-2030)
Table 64. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2024)
Table 67. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2025-2030)
Table 68. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Application (2019-2024)
Table 69. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Application (2025-2030)
Table 70. Chr. Hansen (Jennewein Biotechnologie GmgH) Corporation Information
Table 71. Chr. Hansen (Jennewein Biotechnologie GmgH) Description and Business Overview
Table 72. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product
Table 74. Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments/Updates
Table 75. DSM (Glycom A/S) Corporation Information
Table 76. DSM (Glycom A/S) Description and Business Overview
Table 77. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product
Table 79. DSM (Glycom A/S) Recent Developments/Updates
Table 80. Inbiose Corporation Information
Table 81. Inbiose Description and Business Overview
Table 82. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product
Table 84. Inbiose Recent Developments/Updates
Table 85. Kyowa Hakko Bio Corporation Information
Table 86. Kyowa Hakko Bio Description and Business Overview
Table 87. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product
Table 89. Kyowa Hakko Bio Recent Developments/Updates
Table 90. GeneChem Inc. Corporation Information
Table 91. GeneChem Inc. Description and Business Overview
Table 92. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product
Table 94. GeneChem Inc. Recent Developments/Updates
Table 95. FrieslandCampina Ingredients Corporation Information
Table 96. FrieslandCampina Ingredients Description and Business Overview
Table 97. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product
Table 99. FrieslandCampina Ingredients Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Sialylated Human Milk Oligosaccharides (HMO) Distributors List
Table 103. Sialylated Human Milk Oligosaccharides (HMO) Customers List
Table 104. Sialylated Human Milk Oligosaccharides (HMO) Market Trends
Table 105. Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
Table 106. Sialylated Human Milk Oligosaccharides (HMO) Market Challenges
Table 107. Sialylated Human Milk Oligosaccharides (HMO) Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sialylated Human Milk Oligosaccharides (HMO)
Figure 2. Global Sialylated Human Milk Oligosaccharides (HMO) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sialylated Human Milk Oligosaccharides (HMO) Market Share by Type in 2023 & 2030
Figure 4. 3'-Sialyllactose Product Picture
Figure 5. 6'-Sialyllactose Product Picture
Figure 6. Global Sialylated Human Milk Oligosaccharides (HMO) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Sialylated Human Milk Oligosaccharides (HMO) Market Share by Application in 2023 & 2030
Figure 8. Infant Formula
Figure 9. Food
Figure 10. Others
Figure 11. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size (2019-2030) & (US$ Million)
Figure 13. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (2019-2030) & (Tons)
Figure 14. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price (US$/Kg) & (2019-2030)
Figure 15. Sialylated Human Milk Oligosaccharides (HMO) Report Years Considered
Figure 16. Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Manufacturers in 2023
Figure 17. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Sialylated Human Milk Oligosaccharides (HMO) Players: Market Share by Revenue in 2023
Figure 19. Sialylated Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 22. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2019-2030)
Figure 23. United States Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 26. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2019-2030)
Figure 27. Germany Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Netherlands Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2030)
Figure 34. China Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 42. Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Sialylated Human Milk Oligosaccharides (HMO) by Type (2019-2030)
Figure 53. Global Revenue Market Share of Sialylated Human Milk Oligosaccharides (HMO) by Type (2019-2030)
Figure 54. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Type (2019-2030)
Figure 55. Global Sales Market Share of Sialylated Human Milk Oligosaccharides (HMO) by Application (2019-2030)
Figure 56. Global Revenue Market Share of Sialylated Human Milk Oligosaccharides (HMO) by Application (2019-2030)
Figure 57. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Application (2019-2030)
Figure 58. Sialylated Human Milk Oligosaccharides (HMO) Value Chain
Figure 59. Sialylated Human Milk Oligosaccharides (HMO) Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
